|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0032854,
umls-concept:C0034897,
umls-concept:C0035647,
umls-concept:C0038250,
umls-concept:C0087111,
umls-concept:C0183683,
umls-concept:C0205265,
umls-concept:C0344211,
umls-concept:C0596545,
umls-concept:C0740345,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1518411,
umls-concept:C1521721,
umls-concept:C1555582,
umls-concept:C1561558,
umls-concept:C1705294
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-3-1
|
|
pubmed:abstractText |
Approximately 20% of patients with germ cell tumours do not respond fully to standard therapy, or relapse after treatment. The prognosis of these patients is poor with conventional chemotherapy. Preliminary data suggest that they may have a higher durable response rate with high dose chemotherapy and peripheral blood stem cell support.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0021-1265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
171
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
158-60
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
|
|
pubmed:articleTitle |
High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy.
|
|
pubmed:affiliation |
Department of Medical Oncology, St James's Hospital, Dublin, Ireland. bryanhen@gofree.indigo.ie
|
|
pubmed:publicationType |
Journal Article
|
